Arkhouse, Brigade Capital raise Macy's buyout offer, WSJ reports-March 2024-www.financetom.com

Arkhouse, Brigade Capital raise Macy's buyout offer, WSJ reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Arkhouse, Brigade Capital raise Macy's buyout offer, WSJ reports

Jul 3, 2024 3:49 PM

July 3 (Reuters) - Arkhouse Management and Brigade

Capital Management have raised their bid by about $300 million

for Macy's, the Wall Street Journal reported on Wednesday.

Previous page： Cineplex Launches 'Monday Surprise Premieres' From Nov. 10 Next page： Gogo Says SD Government Division Awarded 5-Year US Federal Contract

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cineplex Launches 'Monday Surprise Premieres' From Nov. 10

Oct 27, 2025

07:56 AM EDT, 10/27/2025 (MT Newswires) -- Cineplex ( CPXGF ) said Monday it is launching its Monday Surprise Premieres, a special event featuring an exclusive mystery screening of a major new release from Nov. 10. Tickets are priced at $8.99 (in-theatre price) and Cineclub members can use their free monthly ticket for this event, a statement said. ...

Gogo Says SD Government Division Awarded 5-Year US Federal Contract

Oct 27, 2025

07:53 AM EDT, 10/27/2025 (MT Newswires) -- Gogo ( GOGO ) said Monday its SD Government division was awarded a five-year contract to supply airborne satellite communications to a US government agency, initially valued at $3 million. The contract is a follow-on from the phase 3 activity of the Small Business Innovation Research program, originally undertaken by SD Government before...

Neumora Therapeutics' Potential Obesity Drug Shows Weight Loss in Preclinical Mice Studies

Oct 27, 2025

07:56 AM EDT, 10/27/2025 (MT Newswires) -- Neumora Therapeutics ( NMRA ) said it received positive preclinical data from three studies with mice for its potential obesity drug NMRA-215. The drug showed weight loss of up to 19% as a monotherapy with semaglutide-like induction and 26% in combination with semaglutide, the company said. Chief Executive and Chairman Paul Berns said...

Top Premarket Decliners

Oct 27, 2025

07:53 AM EDT, 10/27/2025 (MT Newswires) -- Genenta Science (GNTA) shares were nearly 35% lower pre-bell Monday after the company priced overnight a $15 million registered direct offering of American depositary shares. MaxsMaking ( MAMK ) stock was down 23%, paring gains from the previous session. United States Antimony ( UAMY ) shares were 15% lower after Friday's 2.4% gain....